Chapter

Metabolic syndrome

Harold E. Lebovitz

in Oxford Textbook of Endocrinology and Diabetes

Second edition

Published on behalf of Oxford University Press

ISBN: 9780199235292
Published online July 2011 | e-ISBN: 9780199608232 | DOI: http://dx.doi.org/10.1093/med/9780199235292.003.1362

Series: Oxford Textbooks

Metabolic syndrome

Show Summary Details

Preview

The metabolic syndrome (MetS) has been recognized as a clinical entity for more than 50 years. In 1947, Vague described upper body obesity as a predisposing factor in the development of diabetes mellitus, atherosclerosis, and gout. Reaven, in his 1988 Banting lecture, focused on the importance of insulin resistance and a related cluster of metabolic abnormalities that were associated with an increase in coronary artery disease (1). This cluster included resistance to insulin-stimulated glucose uptake, glucose intolerance, hyperinsulinaemia, increased very-low-density lipoprotein (VLDL) triglyceride, decreased high-density lipoprotein (HDL) cholesterol, and hypertension. He called this cluster ‘syndrome X’, and raised the possibility that resistance to insulin-stimulated glucose uptake and hyperinsulinaemia were involved in the aetiology of the metabolic abnormalities and the clinical diseases associated with them. Obesity and, particularly, visceral obesity have been recognized as a major contributor to the MetS since precise techniques to quantitate regional body composition became available. The MetS was initially thought of as an insulin resistance syndrome, implying that insulin resistance was the underlying unifying abnormality.

Chapter.  7523 words.  Illustrated.

Subjects: Endocrinology and Diabetes

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.